Melatonin effects in a patient with severe REM sleep behavior disorder: Case report and theoretical considerations

Neuropsychobiology

Volumn 36, Issue 4, 1997, Pages 211-214

  Kunz, Dieter ^a   Bes, Frederik ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Actigraphy; Melatonin; Motor activity; Parasomnia; REM sleep

Indexed keywords

MELATONIN;

ADULT; ARTICLE; BEHAVIOR DISORDER; BODY MOVEMENT; CASE REPORT; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; MALE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MUSCLE ATONIA; ORAL DRUG ADMINISTRATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP DISORDER; SLEEP PATTERN; TREATMENT OUTCOME;

HUMANS; MALE; MELATONIN; MIDDLE AGED; MOTOR ACTIVITY; POLYSOMNOGRAPHY; SLEEP DISORDERS; SLEEP STAGES; SLEEP, REM;

EID: 0030830445     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119383     Document Type: Article

References (18)

1. Schenck CH, Bundlie SR, Ettingcr MG, Maho-wald MW: Chronic behavioral disorders of human REM sleep: A new category of parasom-nia. Sleep 1986;9:293-308.
2. Mahowald MW, Schenck CH: REM sleep behavior disorder, in Kryger MH, Roth T, Dement WC (eds): Principles and Practice of Sleep Medicine. Philadelphia, Saunders, 1994, pp 574-588.
3. Schenck CH, Garcia-Rill E, Segall M, Noreen H, Mahowald MW: HLA class II genes associated with REM sleep behavior disorder. Ann Neurol 1996;39:261-263.
4. Schenck CH, Mahowald MW, Kim SW, O’Connor KA, Hurwitz TD: Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992;15:226-235.
5. Scharf B, Moskovitz C, Lupton MD, Klawans HL: Dream phenomena induced by chronic levodopa therapy. J Neural Transm 1978:43: 143-151.
6. Schenck CH, Mahowald MW: Long-term nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 1996; 100:333-337.
7. Brown GM: Melatonin in psychiatric and sleep disorder. CNS Drugs 1995;3:209-226.
8. Brzezinski A: Melatonin in humans. N Engl J Med 1997;336:186-195.
9. Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N: Melatonin replacement therapy of elderly insomniacs. Sleep 1995;18:598-603.
10. MacFarlane RJ, Cleghom JM, Brown GM, Streincr DL: The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: A preliminary study. Biol Psychiatry 1991;30:371-376.
11. Wurtmann RJ, Zhdanova I: Improvement of sleep quality by melatonin. Lancet 1995,346: 1491.
12. Zhdanova IV, Wurtmann RJ, Lynch HJ, Ives DR, Dollins AB, Morabito C, Matheson JK, Schomer DL: Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995;57:552-558.
13. Cajochcn C, Krauchi K, Mori D, van Arx M, Wirz-Justice A: Melatonin increases sleepiness and the theta activity in the wake EEG. but does not affect the sleep EEG except to lenght-en the first REM sleep episode. 7th Annu Meet Light Treat Biol Rhythms Frankfurt, June 1995.
14. Anton-Tay F: Melatonin: Effects on brain function; in Costa E, Gessa GL, Sandler M (eds): Serotonin - New Vistas: Biochemistry and Behavioural and Clinical Studies. Advances in Biochemical Psychopharmacology. New York. Raven Press, 1974, vol II, pp 315-324.
15. Dawson D, Encel N: Melatonin and sleep in humans. J Pineal Res 1993;15:1-12.
16. Kupfe DJ, Ehlers CL, Frank E. Grochocinski VJ, McEachran AB, Buhari A: Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment. Biol Psychiatry 1994;35:781-793.
17. Tandon R, Shipley JE, Taylor S, Gredcn JF, Eiser A, DeQuardo J, Goodson J: Electroence-phalographic sleep abnormalities in schizophrenia. Arch Gen Psychiatry 1992:49:185-194.
18. Wirz-Justice A, Armstrong SM: Melatonin; Nature’s soporific? J Sleep Res 1996:5:137-141.